| Phase II Study of Anti-CD19 CAR-T Cells Treating Leukemia Children (NCT04325841) | Beijing Boren Hospital | 2022-03-24 |
| Efficacy of the Use of Bortezomib for the Treatment of Relapsed Leukemia or Positive MRD (NCT05137860) | Hospital General de Mexico | 2021-12-12 |
| Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT (NCT05066958) | Federal Research Institute of Pediatric Hematology, Oncology and Immunology | 2021-09-16 |
| Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse (NCT04475731) | Gruppo Italiano Malattie EMatologiche dell'Adulto | 2021-05-04 |
| CAR-T Cells Combined With Dasatinib for Patients With Relapsed and/or Refractory B-cell Hematological Malignancies (NCT04603872) | Zhejiang University | 2020-11-01 |
| CAR-20/19-T Cells in Patients With Relapsed/Refractory B Cell ALL (NCT04049383) | Medical College of Wisconsin | 2020-10-16 |
| Study of Escalating Doses of INA03 Administered Intravenously as Single Agent in Adult Patients With Relapse/Refractory Acute Leukemia (NCT03957915) | Institut Paoli-Calmettes | 2020-05-29 |
| Study of Anti-CD22 CAR-T Cells Treating Leukemia Children (NCT04340167) | Beijing Boren Hospital | 2020-05-01 |
| Study of Sequential CAR-T Cell Treating Leukemia Children (NCT04340154) | Beijing Boren Hospital | 2020-05-01 |
| CCCG Relapsed Acute Lymphoblastic Leukemia 2017 Study in Children (NCT04224571) | Chinese University of Hong Kong | 2018-09-14 |
| Evaluation of CD19-Specific CAR Engineered Autologous T-Cells for Treatment of Relapsed/Refractory CD19+ Acute Lymphoblastic Leukemia (NCT03573700) | St. Jude Children's Research Hospital | 2018-07-24 |
| Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO) (NCT03751072) | Group for Research in Adult Acute Lymphoblastic Leukemia | 2018-07-16 |
| International Trial of Selumetinib in Combination With Dexamethasone for the Treatment of Acute Lymphoblastic Leukaemia (NCT03705507) | University of Birmingham | 2018-05-18 |
| Treatment With Combination Chemotherapy for Relapsed or Refractory Acute Lymphoblastic Leukemia (NCT03515200) | St. Jude Children's Research Hospital | 2018-04-20 |
| Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Pediatric and Adult Patients With r/r ALL Post HSCT (NCT03389035) | Fondazione Matilde Tettamanti Menotti De Marchi Onlus | 2017-12-20 |
| GRASPA (Erythrocytes Encapsulating L-asparaginase) in Patients With Relapse of Acute Lymphoblastic Leukemia (NCT01518517) | ERYtech Pharma | 2009-12-01 |